Colonics
About Me
Recent Posts
- New Journal Emphasizes Principles Of Injury, Function And Rehabilitation
- Pregnancy and fertility following bariatric surgery
- Barr announces agreements on Nasacort AQ, Allegra D-12 and Allegra patent challenges
- Home-based program to improve exercise and diet improves senior cancer survivors' physical function
- New Cause Of Fatal Brain Injury From Acute Viral Meningitis Discovered By Scripps Research Scientists
Menu
Calendar
| Mon | Tue | Wed | Thu | Fri | Sat | Sun |
|---|---|---|---|---|---|---|
| 1 | 2 | |||||
| 3 | 4 | 5 | 6 | 7 | 8 | 9 |
| 10 | 11 | 12 | 13 | 14 | 15 | 16 |
| 17 | 18 | 19 | 20 | 21 | 22 | 23 |
| 24 | 25 | 26 | 27 | 28 | 29 | 30 |
Friends
Links
Entry 1 of 437
Last Page | Next Page
3/3/2008
-
Metabasis Completes Enrollment Of Its Proof-of-Concept Clinical Trial For MB07803, Its Product Candidate For The Treatment Of Type 2 Diabetes
|
Metabasis Therapeutics, Inc. (Nasdaq:MBRX) be promulgated the completion of patient enrollment in its Phase 2a clinical trial for MB07803, a product candidate being studied as a treatment for career with type 2 diabetes. With this trial fully enrolled and the final mtier undergoing dosing, the Company expects to be able to announce top line results in the second quarter of 2008, as planned. More: - The rest... |
Post A Comment! :: Send to a Friend! |
Share and enjoy
